Skip to content
healthcare.dev

Norel AD

NDC 52747-475, acetaminophen, chlorpheniramine maleate, and phenylephrine HCl, tablet, multilayer, from U.S. PHARMACEUTICAL CORPORATION.

Product NDC
52747-475
Status
Listed
Labeler
U.S. PHARMACEUTICAL CORPORATION
Dosage form
TABLET, MULTILAYER
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52747-475 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAMINOPHEN325 mg/1
  • CHLORPHENIRAMINE MALEATE4 mg/1
  • PHENYLEPHRINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
52747-475-705274704757020 TABLET, MULTILAYER in 1 BOTTLE (52747-475-70)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 52747-475 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52747-475 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52747-475. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.